A 77-year-old woman with congestive heart failure is admitted to the hospital for evaluation prior to cardiac transplantation. During her stay at the hospital, the physician prescribes a drug to improve cardiac contractility. The drug works by selectively inhibiting an isoenzyme that is responsible for the degradation of cyclic adenosine monophosphate. Which of the following is the most likely adverse effect of this drug?
Q442
A 20-year-old girl presents to a physician following unprotected coitus with her boyfriend about 10 hours ago. She tells the doctor that although they usually use a barrier method of contraception, this time they forgot. She does not want to become pregnant. She also mentions that she has major depression and does not want to take an estrogen-containing pill. After necessary counseling, the physician prescribes an enteric-coated pill containing 1.5 mg of levonorgestrel. Which of the following is the primary mechanism of action of this drug?
Q443
A 55-year-old man is discharged from the hospital after being treated for a ST-elevation myocardial infarction. The patient became hypotensive to 87/48 mmHg with a pulse of 130/min. He was properly resuscitated, and a cardiac catheterization with stent placement was performed. Upon being discharged, the patient was started on metoprolol, lisinopril, aspirin, atorvastatin, and nitroglycerin. Upon presentation to the patient’s primary care doctor today, his liver enzymes are elevated with an AST of 55 U/L and an ALT of 57 U/L. Which of the following is the most likely etiology of these laboratory abnormalities?
Q444
A 45-year-old man undergoes an esophagogastroduodenoscopy for his recurrent episodes of epigastric pain. He also lost a significant amount of weight in the last 6 months. He says that he has been taking a number of dietary supplements "to cope". His past medical history is insignificant, and a physical examination is within normal limits. The endoscopy shows a bleeding ulcer in the proximal duodenum. Lab tests reveal a serum iron level of 130 μg/dL. However, his stool guaiac test is negative for occult blood. Over-ingestion of which of the following substances is the most likely cause for this patient’s lab findings?
Q445
A 28-year-old man makes an appointment with his general practitioner for a regular check-up. He has recently been diagnosed with asthma and was given a short-acting β2-agonist to use during acute exacerbations. He said he usually uses the medication 1–2 times per week. Which of the following is the most appropriate treatment in this case?
Q446
A 48-year-old woman visits the clinic with unintentional weight loss for the past 3 months. She is also concerned about difficulty swallowing solid food. She also has early satiety and mild abdominal discomfort. An upper gastrointestinal endoscopy is advised along with a biopsy. The histopathological report reveals gastric adenocarcinoma. She then undergoes a subtotal gastrectomy and is started on an adjuvant chemotherapy regimen with platinum and fluoropyrimidine. 2 weeks later she develops acute respiratory distress and chest pain. A D-dimer test is positive. Her blood pressure is 125/78, heart rate is 110/min, and oxygen saturation is 88%. CT scan of the chest reveals a clot in the anterior segmental artery in the right upper lung. Which of the following therapies should the patient be started on for her acute condition?
Q447
A 57-year-old man comes to the physician because of a 4-week history of constipation, episodic bloody stools, progressive fatigue, and a 5-kg (10.2-lb) weight loss. Digital rectal examination shows a hard, 1.5-cm rectal mass. A biopsy confirms the diagnosis of colorectal carcinoma. The patient begins treatment with a combination chemotherapy regimen that includes a drug that is also used in the treatment of wet age-related macular degeneration. This drug most likely acts by inhibiting which of the following substances?
Q448
A 56-year-old postmenopausal woman comes to the physician because of a 6-month history of worsening pain and swelling in her left knee. She has a history of peptic ulcer disease for which she takes cimetidine. Examination shows palpable crepitus and limited range of motion of the left knee. Which of the following is the most appropriate pharmacotherapy for this patient’s symptoms?
Q449
A 45-year-old man presents with a persistent cough for the past month. He says it started off with a runny nose and fever, from which he recovered in a week, but he says that the cough persists after the resolution of the fever. The patient denies any expectoration, chest pain, weight loss, or breathlessness. He reports no history of recent travel or sick contacts. Past medical history is significant for chronic constipation. He reports a 15-pack-year smoking history but denies any alcohol or current recreational drug use. He says he did use intravenous drugs in his late twenties but quit after going through a drug rehabilitation program. Physical examination is unremarkable. Laboratory findings and a chest radiograph are normal. Which of the following would be the best choice as a cough suppressant in this patient?
Q450
A 65-year-old man presents to the emergency department with shortness of breath. He was at home cleaning his yard when his symptoms began. The patient is a farmer and does not have regular medical care. He has smoked two packs of cigarettes every day for the past 40 years. The patient lives alone and admits to feeling lonely at times. His temperature is 99.5°F (37.5°C), blood pressure is 159/95 mmHg, pulse is 90/min, respirations are 19/min, and oxygen saturation is 86% on room air. On physical exam, you note a man in distress. Pulmonary exam reveals poor air movement, wheezing, and bibasilar crackles. Cardiac exam is notable for an S4 heart sound. The patient is started on appropriate therapy and his symptoms improve. Prior to discharge he is no longer distressed when breathing and his oxygen saturation is 90% on room air. Which of the following interventions could improve mortality the most in this patient?
Autonomic/CV Drugs US Medical PG Practice Questions and MCQs
Question 441: A 77-year-old woman with congestive heart failure is admitted to the hospital for evaluation prior to cardiac transplantation. During her stay at the hospital, the physician prescribes a drug to improve cardiac contractility. The drug works by selectively inhibiting an isoenzyme that is responsible for the degradation of cyclic adenosine monophosphate. Which of the following is the most likely adverse effect of this drug?
A. Hyperkalemia
B. QT interval prolongation
C. Hyperglycemia
D. Bronchospasm
E. Hypotension (Correct Answer)
Explanation: ***Hypotension***
- The drug described is likely a **phosphodiesterase-3 inhibitor** (e.g., milrinone), which increases cyclic AMP in cardiac myocytes and vascular smooth muscle cells.
- Increased **cyclic AMP** in vascular smooth muscle leads to **vasodilation**, causing a drop in systemic vascular resistance and subsequently **hypotension**.
*Hyperkalemia*
- **Hyperkalemia** is not a characteristic adverse effect of phosphodiesterase inhibitors. It is associated with drugs like **ACE inhibitors**, **ARBs**, or **aldosterone antagonists**.
- These drugs primarily affect the **renin-angiotensin-aldosterone system** or potassium excretion.
*QT interval prolongation*
- While some **phosphodiesterase inhibitors** can cause **QT prolongation**, it is not the *most likely* adverse effect compared to hypotension, especially in a patient with heart failure.
- Furthermore, **QT prolongation** is a more prominent concern with drugs like **antiarrhythmics** (e.g., amiodarone, sotalol) or certain **antibiotics** (e.g., macrolides).
*Hyperglycemia*
- **Hyperglycemia** is typically associated with drugs that interfere with **insulin secretion** or **insulin sensitivity**, such as **corticosteroids** or some **atypical antipsychotics**.
- Phosphodiesterase inhibitors do not directly cause significant **glucose disturbances**.
*Bronchospasm*
- **Bronchospasm** is a common side effect of **beta-blockers** due to their antagonism of beta-2 adrenergic receptors in the airways.
- Phosphodiesterase inhibitors, by increasing **cyclic AMP**, would theoretically cause **bronchodilation**, not bronchospasm.
Question 442: A 20-year-old girl presents to a physician following unprotected coitus with her boyfriend about 10 hours ago. She tells the doctor that although they usually use a barrier method of contraception, this time they forgot. She does not want to become pregnant. She also mentions that she has major depression and does not want to take an estrogen-containing pill. After necessary counseling, the physician prescribes an enteric-coated pill containing 1.5 mg of levonorgestrel. Which of the following is the primary mechanism of action of this drug?
A. Atrophy of the endometrium
B. Reduction in motility of cilia in the fallopian tubes
C. Mucosal hypertrophy and polyp formation in cervix
D. Thickening of the cervical mucus
E. Delayed ovulation through inhibition of follicular development (Correct Answer)
Explanation: ***Delayed ovulation through inhibition of follicular development***
- The primary mechanism of action of **levonorgestrel** as emergency contraception is to **inhibit or delay ovulation** by suppressing the luteinizing hormone (LH) surge.
- This prevents the release of an egg, thereby averting fertilization if intercourse has recently occurred.
*Atrophy of the endometrium*
- While progestins can cause endometrial changes, **atrophy** is not the primary mechanism of action for high-dose levonorgestrel in emergency contraception.
- Significant endometrial changes that would prevent implantation typically require longer-term exposure or different formulations.
*Reduction in motility of cilia in the fallopian tubes*
- This is not a primary mechanism of action for **levonorgestrel** as an emergency contraceptive.
- While hormonal changes can influence fallopian tube function, the main contraceptive effect is pre-fertilization.
*Mucosal hypertrophy and polyp formation in cervix*
- **Levonorgestrel** typically causes changes like **thickening of cervical mucus**, not hypertrophy or polyp formation, to impede sperm.
- Mucosal hypertrophy and polyp formation are not considered mechanisms of contraception.
*Thickening of the cervical mucus*
- While **levonorgestrel** does **thicken cervical mucus**, making it harder for sperm to reach the egg, this is a secondary mechanism.
- The primary and most effective action for emergency contraception is the delay of ovulation.
Question 443: A 55-year-old man is discharged from the hospital after being treated for a ST-elevation myocardial infarction. The patient became hypotensive to 87/48 mmHg with a pulse of 130/min. He was properly resuscitated, and a cardiac catheterization with stent placement was performed. Upon being discharged, the patient was started on metoprolol, lisinopril, aspirin, atorvastatin, and nitroglycerin. Upon presentation to the patient’s primary care doctor today, his liver enzymes are elevated with an AST of 55 U/L and an ALT of 57 U/L. Which of the following is the most likely etiology of these laboratory abnormalities?
A. Metoprolol
B. Ischemic hepatitis
C. Lisinopril
D. Nitroglycerin
E. Atorvastatin (Correct Answer)
Explanation: ***Atorvastatin***
- **Statins** (like atorvastatin) are a common cause of drug-induced liver injury, manifesting as elevated liver enzymes (AST and ALT).
- Regular monitoring of liver function tests is recommended when initiating or adjusting statin therapy due to this known side effect.
*Metoprolol*
- While metoprolol can rarely cause liver enzyme elevations, it is **much less common** and typically less pronounced than elevations seen with statins.
- Its primary mechanism of action is related to beta-adrenergic blockade, not direct hepatic toxicity.
*Ischemic hepatitis*
- **Ischemic hepatitis**, also known as shock liver, typically causes a **much more severe and acute increase** in AST/ALT (often in the thousands), usually transiently after a hypotensive episode.
- The mild, persistent elevations described after resuscitation for hypotension make drug-induced injury more likely than resolution of acute ischemic hepatitis.
*Lisinopril*
- **ACE inhibitors** like lisinopril can cause liver enzyme elevations, but this is a **rare adverse effect** and generally not considered a primary contributor in the context of multiple medications, especially when a statin is also prescribed.
- Its hepatic side effects are overshadowed by the more common potential for hyperkalemia or angioedema.
*Nitroglycerin*
- **Nitroglycerin** primarily acts as a vasodilator and is **not commonly associated** with significant elevations in liver enzymes.
- Its metabolism does not typically lead to hepatotoxicity as a common or dose-limiting side effect.
Question 444: A 45-year-old man undergoes an esophagogastroduodenoscopy for his recurrent episodes of epigastric pain. He also lost a significant amount of weight in the last 6 months. He says that he has been taking a number of dietary supplements "to cope". His past medical history is insignificant, and a physical examination is within normal limits. The endoscopy shows a bleeding ulcer in the proximal duodenum. Lab tests reveal a serum iron level of 130 μg/dL. However, his stool guaiac test is negative for occult blood. Over-ingestion of which of the following substances is the most likely cause for this patient’s lab findings?
A. Red meat
B. Folate
C. Tocopherol
D. Ascorbic acid (Correct Answer)
E. Thiamine
Explanation: **Ascorbic acid**
- **Excessive intake of ascorbic acid (vitamin C)** can lead to false-negative stool guaiac tests because it reduces the orthotolidine reagent, interfering with the peroxidase reaction that detects hemoglobin.
- While the patient has a bleeding ulcer, the negative guaiac test despite active bleeding is explained by this **reductive interference** from large doses of vitamin C, which he might be taking as part of his "dietary supplements."
*Red meat*
- **Red meat intake** can cause **false-positive** stool guaiac tests due to the presence of peroxidases in the meat.
- This is the opposite of the patient's presentation, which shows a **false-negative** result.
*Folate*
- **Folate (vitamin B9)** does not significantly interfere with the chemical reaction used in the guaiac test.
- High doses of folate are not known to cause either false-positive or false-negative results in stool occult blood testing.
*Tocopherol*
- **Tocopherol (vitamin E)** does not interfere with the chemical reaction of the guaiac test for occult blood.
- While vitamin E can have some anticoagulant properties at very high doses, it does not directly affect the chemical detection of blood in stool.
*Thiamine*
- **Thiamine (vitamin B1)** does not interfere with the chemical reaction of the guaiac test for occult blood.
- There is no known mechanism by which thiamine supplementation would lead to false-negative results in a stool guaiac test.
Question 445: A 28-year-old man makes an appointment with his general practitioner for a regular check-up. He has recently been diagnosed with asthma and was given a short-acting β2-agonist to use during acute exacerbations. He said he usually uses the medication 1–2 times per week. Which of the following is the most appropriate treatment in this case?
A. He should start using a short-acting β2-agonist every day, not just when he has symptoms.
B. Long-acting β2-agonists should be added to his treatment regimen.
C. Inhaled corticosteroids should be added as controller therapy. (Correct Answer)
D. Systemic corticosteroids should be added to his treatment regimen.
E. He should continue with current treatment.
Explanation: ***Inhaled corticosteroids should be added as controller therapy.***
- The patient's use of a **short-acting β2-agonist (SABA)** 1-2 times per week indicates **persistent asthma** that is not well-controlled, suggesting the need for daily controller therapy.
- **Inhaled corticosteroids (ICS)** are the most effective anti-inflammatory controller medication for asthma and are recommended as the first-line add-on therapy when SABA use exceeds twice a week.
*He should start using a short-acting β2-agonist every day, not just when he has symptoms.*
- **SABAs** are **rescue medications** for acute symptom relief and do not address the underlying airway inflammation in asthma.
- Daily SABA use indicates **poor asthma control** and can lead to adverse effects like **tachycardia** and **tremors**, and may even mask worsening disease.
*Long-acting β2-agonists should be added to his treatment regimen.*
- **Long-acting β2-agonists (LABAs)** should typically **not be used as monotherapy** in asthma due to a potential risk of severe exacerbations and asthma-related deaths.
- LABAs are generally added to an **ICS regimen** when asthma remains uncontrolled despite adequate ICS therapy.
*Systemic corticosteroids should be added to his treatment regimen.*
- **Systemic corticosteroids** are reserved for **severe asthma exacerbations** or for patients with very severe persistent asthma unresponsive to other treatments, given their significant side effects with long-term use.
- The patient's current symptoms do not warrant the immediate use of systemic corticosteroids, which carry risks such as **osteoporosis**, **diabetes**, and **hypertension**.
*He should continue with current treatment.*
- Continuing with SABA monotherapy when used 1-2 times per week indicates **persistent asthma**, which is **suboptimally controlled**.
- Current guidelines suggest that SABA use more than twice weekly warrants a step-up in therapy to include daily controller medication like **inhaled corticosteroids**.
Question 446: A 48-year-old woman visits the clinic with unintentional weight loss for the past 3 months. She is also concerned about difficulty swallowing solid food. She also has early satiety and mild abdominal discomfort. An upper gastrointestinal endoscopy is advised along with a biopsy. The histopathological report reveals gastric adenocarcinoma. She then undergoes a subtotal gastrectomy and is started on an adjuvant chemotherapy regimen with platinum and fluoropyrimidine. 2 weeks later she develops acute respiratory distress and chest pain. A D-dimer test is positive. Her blood pressure is 125/78, heart rate is 110/min, and oxygen saturation is 88%. CT scan of the chest reveals a clot in the anterior segmental artery in the right upper lung. Which of the following therapies should the patient be started on for her acute condition?
A. Warfarin
B. Low-molecular weight heparin (Correct Answer)
C. Aspirin
D. Clopidogrel
E. Ticagrelor
Explanation: ***Low-molecular weight heparin***
- The patient presents with **acute pulmonary embolism (PE)** secondary to cancer, which significantly increases the risk of recurrent VTE. **LMWH** is the preferred treatment for cancer-associated VTE due to its superior efficacy and lower risk of recurrence compared to warfarin.
- Given her **acute respiratory distress**, **chest pain**, **tachycardia**, and **hypoxemia**, immediate anticoagulation is crucial, and LMWH provides a rapid and predictable anticoagulant effect without the need for immediate laboratory monitoring.
*Warfarin*
- While warfarin is an anticoagulant, it has a **slow onset of action** and requires several days to achieve therapeutic levels, making it unsuitable for acute PE.
- Warfarin also interacts with many drugs and requires frequent **INR monitoring**, which can be challenging in a patient receiving chemotherapy for gastric adenocarcinoma.
*Aspirin*
- Aspirin is an **antiplatelet agent** primarily used for arterial thrombosis prophylaxis and is **ineffective in treating acute venous thromboembolism (VTE)** like PE.
- It does not provide sufficient anticoagulation to prevent further clot formation or address the existing pulmonary embolus.
*Clopidogrel*
- Clopidogrel is an **antiplatelet agent** that inhibits platelet aggregation and is used for arterial thrombotic events, such as acute coronary syndromes or prevention of stroke.
- It is **not indicated for the treatment of acute PE** as it does not target the coagulation cascade involved in venous thrombosis.
*Ticagrelor*
- Ticagrelor is another **antiplatelet agent** primarily used in similar indications as clopidogrel (e.g., acute coronary syndromes).
- Like other antiplatelet drugs, it is **ineffective for the treatment of acute venous thromboembolism (VTE)**, which requires anticoagulation.
Question 447: A 57-year-old man comes to the physician because of a 4-week history of constipation, episodic bloody stools, progressive fatigue, and a 5-kg (10.2-lb) weight loss. Digital rectal examination shows a hard, 1.5-cm rectal mass. A biopsy confirms the diagnosis of colorectal carcinoma. The patient begins treatment with a combination chemotherapy regimen that includes a drug that is also used in the treatment of wet age-related macular degeneration. This drug most likely acts by inhibiting which of the following substances?
A. Vascular endothelial growth factor (Correct Answer)
B. Interferon-alpha
C. Metalloproteinase
D. Fibroblast growth factor
E. Epidermal growth factor
Explanation: ***Vascular endothelial growth factor***
- The drug described is likely **bevacizumab**, a monoclonal antibody that targets **VEGF**.
- **VEGF** plays a crucial role in **angiogenesis**, promoting tumor growth and the abnormal blood vessel formation seen in **wet age-related macular degeneration**.
*Interferon-alpha*
- **Interferon-alpha** is an **immunomodulatory cytokine** used in treating certain cancers (e.g., melanoma, renal cell carcinoma) and viral infections (e.g., hepatitis B and C).
- It does not have a role in the direct treatment of **wet age-related macular degeneration**.
*Metalloproteinase*
- **Metalloproteinases** are enzymes involved in **extracellular matrix remodeling** and can contribute to tumor invasion and metastasis, but are not the primary target for the drug described.
- While inhibitors of MMPs have been explored, they are not the class of drugs recognized for dual use in **colorectal cancer** and **wet AMD**.
*Fibroblast growth factor*
- **Fibroblast growth factor (FGF)** is involved in diverse cellular processes including **cell growth, proliferation, and angiogenesis**.
- While FGF signaling can promote tumor growth, it is not the main target of the drug used for both **colorectal carcinoma** and **wet AMD**.
*Epidermal growth factor*
- **Epidermal growth factor (EGF)** and its receptor **EGFR** are targets for certain cancer therapies (e.g., cetuximab, panitumumab) that inhibit cell proliferation and survival.
- However, **EGFR inhibitors** are not used in the treatment of **wet age-related macular degeneration**.
Question 448: A 56-year-old postmenopausal woman comes to the physician because of a 6-month history of worsening pain and swelling in her left knee. She has a history of peptic ulcer disease for which she takes cimetidine. Examination shows palpable crepitus and limited range of motion of the left knee. Which of the following is the most appropriate pharmacotherapy for this patient’s symptoms?
A. Acetylsalicylic acid
B. Diclofenac
C. Meloxicam
D. Celecoxib (Correct Answer)
E. Ketorolac
Explanation: ***Celecoxib***
- This patient suffers from **osteoarthritis** (evidenced by her age, postmenopausal status, knee pain, crepitus, and limited range of motion) and has a history of **peptic ulcer disease (PUD)**. **Celecoxib** is a **COX-2 selective NSAID**, which reduces the risk of gastrointestinal side effects compared to non-selective NSAIDs.
- Given her history of PUD, a COX-2 selective NSAID is the most appropriate choice to manage her pain while minimizing the risk of a PUD exacerbation or bleed.
*Acetylsalicylic acid*
- **Aspirin** (acetylsalicylic acid) is a non-selective NSAID and would pose a significant risk of **gastrointestinal bleeding** or ulcer exacerbation in a patient with a history of **peptic ulcer disease**.
- While it has anti-inflammatory properties, its adverse effect profile makes it unsuitable for this patient's chronic pain management.
*Diclofenac*
- **Diclofenac** is a **non-selective NSAID**, meaning it inhibits both COX-1 and COX-2 enzymes.
- Due to its inhibition of COX-1, it carries an increased risk of **gastric ulcers** and bleeding, making it less safe for a patient with a history of **peptic ulcer disease**.
*Meloxicam*
- **Meloxicam** is a partially COX-2 selective NSAID, but it still has some affinity for COX-1 at higher doses, conferring a risk for **gastrointestinal adverse effects**.
- Although it may have a slightly better GI safety profile than non-selective NSAIDs, **celecoxib** offers superior GI protection.
*Ketorolac*
- **Ketorolac** is a potent **non-selective NSAID** primarily used for short-term management of moderate to severe acute pain, often administered parenterally.
- Its use is associated with a high risk of **gastrointestinal toxicity** and renal impairment, making it inappropriate for chronic pain management in a patient with **peptic ulcer disease**.
Question 449: A 45-year-old man presents with a persistent cough for the past month. He says it started off with a runny nose and fever, from which he recovered in a week, but he says that the cough persists after the resolution of the fever. The patient denies any expectoration, chest pain, weight loss, or breathlessness. He reports no history of recent travel or sick contacts. Past medical history is significant for chronic constipation. He reports a 15-pack-year smoking history but denies any alcohol or current recreational drug use. He says he did use intravenous drugs in his late twenties but quit after going through a drug rehabilitation program. Physical examination is unremarkable. Laboratory findings and a chest radiograph are normal. Which of the following would be the best choice as a cough suppressant in this patient?
A. Oxymetazoline
B. Pseudoephedrine
C. Guaifenesin
D. Dextromethorphan (Correct Answer)
E. Codeine
Explanation: ***Dextromethorphan***
- Dextromethorphan is a commonly used **cough suppressant** that acts on the cough center in the medulla, making it a good choice for **non-productive coughs** after ruling out serious etiologies.
- Its mechanism of action involves elevating the **cough threshold**, providing symptomatic relief for the persistent cough described.
*Oxymetazoline*
- **Oxymetazoline** is a topical **nasal decongestant** that causes vasoconstriction in the nasal passages.
- It is primarily used for the relief of **nasal congestion** and rhinitis, not as a cough suppressant.
*Pseudoephedrine*
- **Pseudoephedrine** is an oral **decongestant** that works by vasoconstriction to reduce nasal and sinus congestion.
- It does not directly suppress cough and is primarily indicated for symptoms related to **upper airway congestion**.
*Guaifenesin*
- **Guaifenesin** is an **expectorant** that thins bronchial secretions, making them easier to clear.
- It is used for **productive coughs** to help expel mucus, not to suppress a dry, non-productive cough.
*Codeine*
- **Codeine** is an opioid that effectively suppresses cough but carries risks of **sedation**, **constipation**, and potential for **abuse**.
- Given the patient's history of chronic constipation and past intravenous drug use, **opioid-based cough suppressants** like codeine should be avoided due to potential for adverse effects and relapse.
Question 450: A 65-year-old man presents to the emergency department with shortness of breath. He was at home cleaning his yard when his symptoms began. The patient is a farmer and does not have regular medical care. He has smoked two packs of cigarettes every day for the past 40 years. The patient lives alone and admits to feeling lonely at times. His temperature is 99.5°F (37.5°C), blood pressure is 159/95 mmHg, pulse is 90/min, respirations are 19/min, and oxygen saturation is 86% on room air. On physical exam, you note a man in distress. Pulmonary exam reveals poor air movement, wheezing, and bibasilar crackles. Cardiac exam is notable for an S4 heart sound. The patient is started on appropriate therapy and his symptoms improve. Prior to discharge he is no longer distressed when breathing and his oxygen saturation is 90% on room air. Which of the following interventions could improve mortality the most in this patient?
A. Varenicline (Correct Answer)
B. Albuterol
C. Ipratropium
D. Home oxygen
E. Magnesium
Explanation: ***Varenicline***
- This patient presents with symptoms highly suggestive of an **acute exacerbation of COPD** (shortness of breath, poor air movement, wheezing, significant smoking history). **Smoking cessation** is the single most effective intervention to improve mortality in patients with COPD, and varenicline is a highly effective medication for this purpose.
- While other interventions manage acute symptoms, quitting smoking addresses the underlying progressive lung damage and **reduces the risk of future exacerbations and overall mortality**.
*Albuterol*
- **Albuterol** is a **short-acting beta-agonist (SABA)** used as a rescue inhaler to provide rapid bronchodilation during an acute exacerbation of COPD.
- While essential for **symptomatic relief** and managing acute episodes, it does not impact the long-term progression of COPD or overall mortality.
*Ipratropium*
- **Ipratropium** is a **short-acting muscarinic antagonist (SAMA)** that also causes bronchodilation and is used in the acute management of COPD exacerbations, often in combination with SABAs.
- Like albuterol, it provides **symptomatic relief** but does not alter the disease course or improve long-term mortality.
*Home oxygen*
- **Home oxygen therapy** is indicated for patients with severe, chronic hypoxemia (PaO2 < 55 mmHg or SaO2 < 88%) on room air to improve quality of life and decrease mortality.
- While beneficial for select patients with **chronic hypoxemia**, it is not a primary intervention for acute exacerbations or a more impactful mortality-reducing strategy than smoking cessation for a patient who continues to smoke.
*Magnesium*
- **Intravenous magnesium sulfate** can be considered in severe, life-threatening asthma exacerbations or acute COPD exacerbations that are unresponsive to standard bronchodilator therapy.
- It works by inducing **bronchial smooth muscle relaxation** but is a therapy for acute rather than chronic management or mortality improvement.